Comment Period Extended on Marketing Unapproved Drugs Guide
02/27/2004
Federal Register Notice: FDA is reopening until 4/27 the comment period on the draft guidance for industry entitled Marketing Unapproved Drugs; Compliance Policy Guide. To download the guidance, click here. To view this notice, click here.
